India, Israel, Russia, Saudi Arabia, South Korea, Taiwan, Singapore, and Switzerland. The drug is the result of a long-standing collaboration between BioArctic and Eisai, and the antibody was ...

TOKYO -- Japanese drugmaker Eisai will make its Alzheimer's disease ... with the company planning to later roll out home use in China and India. "The new formulation will be a game changer in ...

Japanese pharma group Eisai says it is battling a ransomware attack that was launched last weekend and has resulted in some of its servers becoming encrypted. The attack has affected servers both ...

Jan 24 (Reuters) - Merck (MRK.N), opens new tab and Japan-based Eisai (4523.T), opens new tab said on Friday a combination of their therapies failed to extend the lives of patients with a type of ...

Eisai Inc. announced today that screening for Study E2086-A001-101 (Study 101) to assess the efficacy, safety and tolerability of E2086, a novel selective orexin-2 receptor, is now registered on ...